Dr. Chris Towler PhDNon-Executive Director

    Chris Towler spent 23 years at Glaxo and GlaxoWellcome, 13 of which were as leader of a project management organisation within the Development Directorate, followed by a period as head of International and Manufacturing Regulatory Affairs.

    Chris led the development teams responsible for bringing a number of major novel therapies including Imigran, Zofran and Relenza to the market, served as a member of the Corporate Strategy Team and was closely involved with organisational change and post-merger integration projects.

    He joined Imperial College London in 2001 to assist the new Vice Chancellor, Sir Richard Sykes, particularly in the realms of strategic planning, complex project management, commercialisation of science and communication before joining Oxford University in 2008 as Director of Oxford Spinout Equity Management.

    He holds a PhD in Biochemistry and undertook a number of years of post-doctoral research in the area of onco-foetal antigens and placental growth monitoring.

    Contact Us

    Want to get in touch? Send us an email.

    Not readable? Change text. captcha txt